The ownership structure of Scinai Immunotherapeutics (DE:2F5) stock is a mix of institutional, retail, and individual investors. Approximately 2.15% of the company’s stock is owned by Institutional Investors, 7.40% is owned by Insiders, and 90.45% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}
Top Shareholders
Holder
# of Shares
Type
% Holding
Value
62,400
Insider
7.40%
223,891
137
Institution
0.02%
492
2
Institution
<0.01%
7
Top Mutual Fund Holders
Holder
# of Shares
Type
% Holding
Value
137
Institution
0.02%
492
Top ETF Holders
Holder
# of Shares
Type
% Holding
Value
FAQ
Who Owns Scinai Immunotherapeutics (DE:2F5)?
According to the latest TipRanks data, approximately 2.13% of the company's stock is held by institutional investors, 7.40% is held by insiders, and 90.45% is held by retail investors.
What percentage of Scinai Immunotherapeutics (DE:2F5) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.13% of Scinai Immunotherapeutics (DE:2F5) stock is held by institutional investors.
What percentage of Scinai Immunotherapeutics (DE:2F5) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.45% of Scinai Immunotherapeutics (DE:2F5) stock is held by retail investors.
Who owns the most shares of Scinai Immunotherapeutics (DE:2F5)?
STONE DANIEL E. owns the most shares of Scinai Immunotherapeutics (DE:2F5).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.